The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Obesity associated disease risk: the role of inherent differences and location of adipose depots
Abstract
Obesity and associated metabolic co-morbidities are a worldwide public health problem. Negative health outcomes associated with obesity, however, do not arise from excessive adiposity alone. Rather, deleterious outcomes of adipose tissue accumulation are a result of how adipocytes are distributed to individual regions in the body. Due to our increased understanding of the dynamic relationship that exists between specific adipose depots and disease risk, an accurate characterization of total body adiposity as well as location is required to properly evaluate a population’s disease risk. Specifically, distinctive tissue depots within the body include the lower body, upper body and abdominal (deep and superficial) subcutaneous regions, as well as visceral (mesenteric and omental) regions. Upper body and visceral adipose tissues are highly associated with metabolic dysfunction and chronic disease development, whereas lower body gluteofemoral subcutaneous adipose tissue imparts protection against diet-induced metabolic derangement. Each adipose depot functions distinctly as an endocrine organ hence it has a different level of impact on health outcomes. Effluent from adipose tissue can modulate the functions of other tissues, whilst receiving differential communication from the rest of the body via central nervous system innervation, metabolites and other signaling molecules. More so, adipose depots contain a diverse reservoir of tissue-resident immune cells that play an integral part in both maintaining tissue homeostasis, as well as propagating metabolically-induced inflammation. Overall, the conceptualization of obesity and associated risks needs updating to reflect the complexities of obesity. We review adipose tissue characteristics that are linked to deleterious or beneficial adipose tissue distributions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In women, the transition to menopause significantly increases metabolic risk, with postmenopausal women facing a five times greater risk of central obesity compared to premenopausal women (6–8).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [7]
In the citing paper
“This significant shift in fat distribution from subcutaneous regions in the hips and thighs to visceral depots is attributed to the loss of ovarian sex steroid production, in which case, adipose tissue then becomes the primary site of estrogen production (7, 9).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [7]
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354
Prevalence of Obesity Among Adults and Youth: United States, 2015-2016.
Hales, C. M., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2017) · PubMed · Cited by 3,884
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Cited by
Nutrition and cognitive health: A life course approach
Puri, S., Shaheen, M., & Grover, B. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1023907 · Cited by 224
Christakoudi, S., Tsilidis, K. K., Muller, D. C., Freisling, H., Weiderpass, E., Overvad, K., Söderberg, S., Häggström, C., Pischon, T., Dahm, C. C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71302-5 · Cited by 220
Christakoudi, S., Εvangelou, Ε., Ríboli, E., & Tsilidis, K. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-89176-6 · Cited by 146
“6 within 1 Mb window) for WHIUKB (n = 1,988) or WHRadjBMI (n = 1,959) in women; (b) independent significant SNPs for ABSIUKB (n = 1,273) or WCadjBMI (n = 1,586) in women; (c) independent significant SNPs for HIUKB (n = 814) or HCadjBMI (n = 2,008) in women; (d) independent significant SNPs for WHIUKB (n = 617) or WHRa…”
BackgroundNeutrophils Actively Contribute to Obesity-Associated Inflammation and Pathological Complications
Uribe‐Querol, E., & Rosales, C. (2022) · Cells · doi:10.3390/cells11121883 · Cited by 133
Therapeutic Effects of Butyrate on Pediatric Obesity: A Randomized Clinical Trial
Coppola, S., Nocerino, R., Paparo, L., Bedogni, G., Calignano, A., Scala, C. D., Severina, A. F. D. G. D. S., Filippis, F. D., Ercolini, D., & Canani, R. B. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.44912 · Cited by 123
Metadata
- Authors
- Hill, J. H., Solt, C., & Foster, M. T.
- Affiliations
- Department of Food Science and Human Nutrition , Colorado State University , Fort Collins, CO , USA
- Colorado State University (US)
- Corresponding author
- Foster, Michelle T.
- ORCID
- Foster, Michelle T.
- Venue
- Hormone Molecular Biology and Clinical Investigation
- Publisher
- Walter de Gruyter GmbH
- Published
- 2018-02-01
- Volume
- 33
- Issue
- 2
- ISSN
- 1868-1883 (ISSN-L)
- 1868-1891
- OpenAlex
- W2971283455
- Cited by
- 79
- References
- 214
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 7 · 2023: 11 · 2022: 12 · 2021: 16 · 2020: 16 · 2019: 4 · 2018: 2
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hormone Molecular Biology and Clinical Investigation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- obesity, body fat distribution, adipose depots, visceral adipose tissue, subcutaneous adipose tissue, abdominal fat, metabolic comorbidities, adipose tissue endocrine function, adipose tissue inflammation, tissue-resident immune cells, disease risk
- MeSH terms
- Adipose Tissue, Animals, Cardiovascular Diseases, Diabetes Mellitus, Humans, Immunity, Cellular, Inflammation, Obesity, Body Mass Index, Adiposity, Adipokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obesity associated disease risk: the role of inherent differences and location of adipose depots. https://app.cochat.ai/papers/10.1515/hmbci-2018-0012
- The paper
- Hill, J. H., Solt, C., & Foster, M. T. (2018). Obesity associated disease risk: the role of inherent differences and location of adipose depots. Hormone Molecular Biology and Clinical Investigation. https://doi.org/10.1515/hmbci-2018-0012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.